KIP Infrastructure
2.27.3 -
This page is part of the KIP Infrastructure (v2.27.3: Release) based on FHIR (HL7® FHIR® Standard) R4. This is the current published version. For a full list of available versions, see the Directory of published versions
| Official URL: https://kip.rkkp.dk/fhir/ValueSet/Radioimmunoterapi | Version: 2.27.3 | |||
| Active as of 2022-07-18 | Computable Name: Radioimmunoterapi | |||
Radioimmunoterapi
References
This value set is not used here; it may be used elsewhere (e.g. specifications and/or implementations that use this content)
This value set includes codes based on the following rules:
https://kip.rkkp.dk/fhir/CodeSystem/GenericValues version 📦2.27.3| Code | Display | Definition |
| none | Ingen radioimmunoterapi | None - used to choose none of the available values |
https://kip.rkkp.dk/fhir/CodeSystem/ATC version 📦2.27.3
| Code | Display | Definition |
| V10XA53 | Bexxar | V10XA53 - tositumomab/iodine (131I) tositumomab |
| V10XX02 | Zevalin | V10XX02 - ibritumomab tiuxetan (90Y) |
| V10X | Anden RIT | V10X - OTHER THERAPEUTIC RADIOPHARMACEUTICALS |
Expansion performed internally based on:
This value set contains 4 concepts
| System | Code | Display (en) | Definition | JSON | XML |
https://kip.rkkp.dk/fhir/CodeSystem/GenericValues | none | Ingen radioimmunoterapi | None - used to choose none of the available values | ||
https://kip.rkkp.dk/fhir/CodeSystem/ATC | V10XA53 | Bexxar | V10XA53 - tositumomab/iodine (131I) tositumomab | ||
https://kip.rkkp.dk/fhir/CodeSystem/ATC | V10XX02 | Zevalin | V10XX02 - ibritumomab tiuxetan (90Y) | ||
https://kip.rkkp.dk/fhir/CodeSystem/ATC | V10X | Anden RIT | V10X - OTHER THERAPEUTIC RADIOPHARMACEUTICALS |